Navigation Links
Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute
Date:1/28/2008

New York, New York The Cancer Research Institute (CRI) announced today that it has brought together the Cancer Vaccine Consortium, a program of the Sabin Vaccine Institute, and the Cancer Vaccine Collaborative, a program of the Cancer Research Institute (CRI) and the Ludwig Institute for Cancer Research (LICR), to form the leading initiative on cancer vaccines. This joint effort establishes a unified voice in the cancer vaccine field and provides a major new resource to academia, industry, and governmental agencies involved in cancer vaccine discovery and development.

The Cancer Vaccine Consortium, now administered by the Cancer Research Institute, is an international association of 67 pharmaceutical, biotechnology, and academic institutions engaged in cancer vaccine and immunotherapy research and development. The Cancer Vaccine Collaborative is a coordinated global network of 22 academic clinical and laboratory centers with strong immune monitoring capabilities and the capacity to conduct early-phase clinical trials.

Linking these programs under a single organization offers great synergism for academic and industrial collaboration and provides improved capabilities for all its members. Together, the two programs aim to address the needs of the immunotherapy community with the goal to accelerate discovery and development, and facilitate regulatory discussions about cancer vaccines and other immunotherapies.

The objectives and activities of the new Cancer Vaccine Consortium will encompass:

  • Hosting scientific conferences and workshops on cancer vaccines and other immunotherapies to facilitate knowledge exchange;
  • Forming alliances with academic and industrial organizations across the globe to further accelerate progress;
  • Facilitating ongoing dialogue with regulatory bodies to help develop needed standards for evaluating cancer immunotherapies;
  • Developing and standardizing methodologies for measuring the
    '/>"/>

Contact: Brian Brewer
bbrewer@cancerresearch.org
212-688-7515
Cancer Research Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Teens, Young Adults Missing Out on Latest Cancer Advances
2. Oral Contraceptives Cut Ovarian Cancer Risk
3. TNF-alpha antagonist stops inflammation-induced colon cancer in its tracks
4. New Colon Cancer Test Might Spot Trouble Earlier
5. Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute
6. Synthesis of natural molecule could lead to better anti-cancer drugs
7. Engineers use bloods hydrodynamics to manipulate stem, cancer cells
8. Combination therapy improves survival for certain prostate cancer patients
9. Hormone Therapy Only Helps Some Older Men With Prostate Cancer
10. Cell division studies hint at future cancer therapy
11. Regular, long-term aspirin use reduces risk of colorectal cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Since 1996, crop plants genetically modified to ...in insects, yet safe for people, have been planted...popularity of these Bt crops, named after the bact...bility to kill some major pests, allowing farmers ...reducing insecticide sprays. , However, since in...
(Date:11/23/2009)...Study found one more than doubled chances, while b... Nov. 23 (HealthDay News) -- Children whose mother...ead have more than double the risk of having atten...r children, new research shows. , And with expo...aving ADHD soared. Children whose mothers smoked d...
(Date:11/23/2009)...,, DALLAS,Nov.23/PRNewswire/--TheBerylCompani...rservicesforthehealthcareindustry,hasearnedrecogni...dernHealthcare ,theindustry,sleadingtrademagazine....gfirmsbasedonBeryl,s2008businessresults,whichenabl..., Berylattributesthisgrowthtoitsinnovativeproduct...
(Date:11/23/2009)... Information about Oxycod... launched DopeStats.com. The new site is a statist... use rates of Oxycodone in each county in the Unit...e who have used the drug for recreational or medic...FL (PRWEB) November 23, 2009 -- Legal and illegal ...
(Date:11/23/2009)... Summary: People are hire...onalities. Personality assessments give insight in...ormance. The Candidate Potential Report assesses a...summarizes the recommendation for job fit and pote...ybrook, CT (PRWEB) November 23, 2009 -- When does ...
Breaking Medicine News(10 mins):Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 3Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2Health News:DopeStats.com Provides Statistics on Oxycodone Abused in Non-Medical Purposes 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 2Health News:Candidate Potential Report Reduces Risk of Bad Hires 3
...lly Residents to Eat Right, Move More and Milk ...ho, May 29 The last decade can be defined by,the ... to go in and out of,fashion like shoulder pads an..., A new campaign crossing the country, the Campai...
...armaceutical Industries,Ltd. (Reuters: SUN.BO, Blo...y sent a letter to Barrie Levitt, M.D., Chairman o...Sheets: TAROF) regarding Taro,s purported,terminat...he merger as per our agreement. We remain,skeptica...
...08 - Children who can read and have good phonetic ...ounds within words may still be poor spellers. In..., Elizabeth Eglinton and Marian Annett, at the Sch...year study was carried out in a cohort of children...
...umers about Urinary Health, CROMWELL, Conn., May ...nary tract infections (UTIs) are the second most c...or more than 8 million doctor visits,each year. On...omen do not realize the signs of a UTI in the firs...
...n Up To Three Times as Many Calories as,Hand-Held,... the Nintendo Wii, are quickly becoming the most c...ainment value, these systems appear to,be helpful ...ACSM)., One of the studies presented today examin...
...ain Stable or Improve in 83% of Patients ...y 29 /PRNewswire-FirstCall/ - Novadaq(R) Technolog...cal imaging and image guidance,systems for the ope...d with the OPTTX(R) System in commercial practice ...
Other Medicine News:Health News:Message to Idaho Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Idaho Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 2Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 4Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 5Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 6Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 7Health News:AZO Answers the Burning Question: What's Up Down There? 2Health News:AZO Answers the Burning Question: What's Up Down There? 3Health News:AZO Answers the Burning Question: What's Up Down There? 4Health News:Kids' Energy Expenditure High in Active Video Games 2Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 2Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 3Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 4
(Date:11/20/2009)..., CARY, N.C., Nov. 20 ... specialty pharmaceutical company focused on acqui...roducts primarily for the respiratory and related ...ning Letter from the Food and Drug Administration ...lets (Phenylephrine HCl 10 mg, Pyrilamine Maleate ...
(Date:11/20/2009)..., GLENWOOD, Ill., Nov. 20 /PRNewswire-FirstCall/...ncial results for the fiscal fourth quarter and fu... 2009. ,, The company will host a conference ca...2:00 p.m. Eastern Time. Investors may access the l...d States and Canada), or 480-629-9835 (internation...
(Date:11/20/2009)... , HARRISBURG, Pa., Nov. 20 /PRNewswire-USNewsw...ding free H1N1 flu shots to members of priority gr...ine. ,, A total of 18 clinics are being held st...rom 2 p.m. to 8 p.m. Hours on Saturday, Nov. 21, w...inics will operate from 2 p.m. to 8 p.m. ,, In...
Breaking Medicine Technology:Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2The KonLin Letter Issues Featured Stock Update on Nuvilex Inc in Its September 2009 Edition 56162 1The KonLin Letter Issues Featured Stock Update on Nuvilex Inc in Its September 2009 Edition 56162 2The KonLin Letter Issues Featured Stock Update on Nuvilex Inc in Its September 2009 Edition 56162 3The KonLin Letter Issues Featured Stock Update on Nuvilex Inc in Its September 2009 Edition 56162 4XLHealth Appoints New Controller to Lead Financial Compliance Accounting Initiatives 56160 1XLHealth Appoints New Controller to Lead Financial Compliance Accounting Initiatives 56160 2Join The Wound Ostomy 26 Continence Nurses Society As It Makes History 56155 1Join The Wound Ostomy 26 Continence Nurses Society As It Makes History 56155 2
...,Forest Laboratories, Inc. (NYSE: FRX ) and Gedeo...ults from a U.S. conducted randomized,double-blind... novel,antipsychotic, in 389 schizophrenia patient...nge from baseline to Week 6 on the Positive and,Ne...ated a nominally,statistically significant (i.e., ...
... Suffer From Condition, NEW YORK, Oct. 15 The fi...(dispensing), stents can benefit patients,who suff...g place at,Montefiore Medical Center, one of only ...edicated, drug-coated stents have been used with g...g coronary artery disease. PAD affects more than ...
Other Medicine Technology:Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia 2Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia 3Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia 4Peripheral Arterial Disease to be Treated With New Medicated Stent in Trial at Montefiore 2
FF 450plus IR
... for fast and easy operation with advanced lens me...utomatically held when the lens is properly aligne...The sophisticated alignment system guides you to c...designed with a small footprint, occupying little ...
CR6-45NM Non-Mydriatic Retinal Camera
TRC-50FXC
Medicine Products: